Advertisement
Canada markets close in 1 hour 53 minutes
  • S&P/TSX

    24,448.38
    -22.79 (-0.09%)
     
  • S&P 500

    5,828.20
    -31.65 (-0.54%)
     
  • DOW

    42,826.02
    -239.20 (-0.56%)
     
  • CAD/USD

    0.7245
    -0.0004 (-0.06%)
     
  • CRUDE OIL

    70.39
    -3.44 (-4.66%)
     
  • Bitcoin CAD

    92,591.73
    +2,005.49 (+2.21%)
     
  • XRP CAD

    0.75
    -0.00 (-0.29%)
     
  • GOLD FUTURES

    2,680.40
    +14.80 (+0.56%)
     
  • RUSSELL 2000

    2,268.00
    +19.36 (+0.86%)
     
  • 10-Yr Bond

    4.0450
    -0.0530 (-1.29%)
     
  • NASDAQ

    18,341.42
    -161.27 (-0.87%)
     
  • VOLATILITY

    20.14
    +0.44 (+2.23%)
     
  • FTSE

    8,249.28
    -43.38 (-0.52%)
     
  • NIKKEI 225

    39,910.55
    +304.75 (+0.77%)
     
  • CAD/EUR

    0.6652
    +0.0010 (+0.15%)
     

IQVIA: Q2 Earnings Snapshot

DURHAM, N.C. (AP) — DURHAM, N.C. (AP) — IQVIA Holdings Inc. (IQV) on Monday reported second-quarter earnings of $363 million.

The Durham, North Carolina-based company said it had net income of $1.97 per share. Earnings, adjusted for one-time gains and costs, came to $2.64 per share.

The results surpassed Wall Street expectations. The average estimate of 10 analysts surveyed by Zacks Investment Research was for earnings of $2.58 per share.

The clinical testing company posted revenue of $3.81 billion in the period, which also beat Street forecasts. Nine analysts surveyed by Zacks expected $3.79 billion.

IQVIA expects full-year earnings in the range of $11.10 to $11.30 per share, with revenue in the range of $15.43 billion to $15.53 billion.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on IQV at https://www.zacks.com/ap/IQV